MRKR
Marker Therapeutics, Inc.Company with tickers: MRKR
CIK
1094038
CUSIP
57055L206
Shares Outstanding
16,673,127
13F Activity (30d)
33 filings
33 filers
Price
$1.45
Market Cap
$24.18M
P/E Ratio
-1.22
EPS (Diluted)
$-1.19
52W High
$4.07
52W Low
$0.81
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $4,957,777 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $3,135,427 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-4,957,777 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-4,446,184 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.40 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.40 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |